EAGLE PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2022.
  • Eagle Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was $10.3M, a 368% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was $41M, a 29% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was $81M, a 2824% increase from 2021.
  • Eagle Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was $2.77M, a 91.6% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was $33M, a 51.1% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $81M +$78.2M +2824% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-23
2021 $2.77M -$30.2M -91.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $33M +$11.1M +51.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $21.8M -$14.8M -40.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 $36.6M -$37.4M -50.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-05
2017 $74M +$20.6M +38.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $53.4M +$50.8M +1984% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $2.56M +$21.3M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 -$18.8M -$10.3M -122% Oct 1, 2013 Sep 30, 2014 10-K 2017-03-15
2013 -$8.46M +$11.4M +57.4% Oct 1, 2012 Sep 30, 2013 10-K 2016-02-29
2012 -$19.8M Oct 1, 2011 Sep 30, 2012 10-K 2014-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.